Corvus Pharmaceuticals, Inc. (CRVS)
20.61
+0.15
(+0.73%)
USD |
NASDAQ |
Feb 09, 15:27
Corvus Pharmaceuticals Total Liabilities (Quarterly) : 8.706M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Plus Therapeutics, Inc. | 13.62M |
| Geron Corp. | 318.68M |
| Jaguar Health, Inc. | 45.11M |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 80.47M |
| Shareholders Equity (Quarterly) | 71.77M |
| Debt to Equity Ratio | 0.0141 |
| Current Ratio | 8.291 |
| Net Debt Paydown Yield | -0.01% |